Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects.

Int J Mol Sci · 2023 · PMC10607383 · PMID 37895000

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, although the combination of nivolumab and chemotherapy led to significant OS and PFS benefits for patients with a CPS of ≥5, long-term results for nivolumab plus ipilimumab versus chemotherapy did not reach statistical significance [ 48 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.